Singapore, May 8 -- Bengaluru-based Indegene, a digital-first, life sciences commercialisation company which has opened its initial public offering on May 06, is oversubscribed by 7.35 times on the second day.

By keeping investors' confidence high even on the second day, Indegene received good response from Non Institutional Investors (Bid amount of more than Rs 10 lakh) with 19.26 times subscription while Non Institutional Investors (Bid amount of more than Rs 2 lakh and upto Rs 10 lakh) 15.56 times. The quota for Qualified Institutional Buyers (QIBs) got subscribed 5.59 times while the portion for retail investors received 3.82 times subscription.

The company intends to use the proceeds of the Fresh Issue utilize towards funding the ...